2014
DOI: 10.1016/j.maturitas.2013.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Dementia prevention: Shared questions for research and clinical management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…With the advent of the prevention clinical trials in dementia, such as DIAN-TU for AD in pre-symptomatic mutation carriers, disclosure of genetic status is a pre-condition to participate in a trial in Italy. Such disclosure cannot be made without effective pre-and post-genetic testing support [28].…”
Section: Introductionmentioning
confidence: 99%
“…With the advent of the prevention clinical trials in dementia, such as DIAN-TU for AD in pre-symptomatic mutation carriers, disclosure of genetic status is a pre-condition to participate in a trial in Italy. Such disclosure cannot be made without effective pre-and post-genetic testing support [28].…”
Section: Introductionmentioning
confidence: 99%